Header cover image

Japanese (NIKKEI) Pharma Industry Analysis

UpdatedApr 26, 2024
DataAggregated Company Financials
Companies40
  • 7D0.5%
  • 3M-1.9%
  • 1Y3.1%
  • YTDn/a

The Pharma industry is up 2.7% in the last week, with Daiichi Sankyo Company up 5.1%. In the last 12 months, the industry was up 4.7%. Earnings are forecast to grow by 13% annually.

Industry Valuation and Performance

Has the Japanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Apr 2024JP¥39.0tJP¥14.7tJP¥1.2t18.5x32.3x2.7x
Sun, 24 Mar 2024JP¥43.3tJP¥15.1tJP¥1.2t20.1x35.6x2.9x
Tue, 20 Feb 2024JP¥42.2tJP¥15.1tJP¥1.2t20.7x34.8x2.8x
Thu, 18 Jan 2024JP¥41.5tJP¥15.2tJP¥1.4t20x30.2x2.7x
Sat, 16 Dec 2023JP¥38.8tJP¥15.2tJP¥1.4t19.1x28.2x2.6x
Mon, 13 Nov 2023JP¥38.7tJP¥15.1tJP¥1.4t22x28.2x2.6x
Wed, 11 Oct 2023JP¥39.8tJP¥14.9tJP¥1.4t23.6x27.8x2.7x
Fri, 08 Sep 2023JP¥40.4tJP¥14.9tJP¥1.4t23.3x28.3x2.7x
Sun, 06 Aug 2023JP¥38.6tJP¥14.9tJP¥1.4t21.1x27.1x2.6x
Tue, 04 Jul 2023JP¥40.3tJP¥14.6tJP¥1.5t21x27.5x2.8x
Thu, 01 Jun 2023JP¥39.3tJP¥14.6tJP¥1.5t19.5x26.9x2.7x
Sat, 29 Apr 2023JP¥38.7tJP¥14.3tJP¥1.5t18.2x26.4x2.7x
Mon, 27 Mar 2023JP¥36.6tJP¥14.3tJP¥1.5t16.6x24.9x2.6x
Wed, 22 Feb 2023JP¥37.1tJP¥14.3tJP¥1.5t17.2x25.3x2.6x
Fri, 20 Jan 2023JP¥36.6tJP¥13.7tJP¥1.4t19.2x27.1x2.7x
Sun, 18 Dec 2022JP¥39.5tJP¥13.7tJP¥1.3t18.4x29.3x2.9x
Tue, 15 Nov 2022JP¥38.0tJP¥13.7tJP¥1.4t18.5x28.1x2.8x
Thu, 13 Oct 2022JP¥37.8tJP¥13.3tJP¥1.4t17.9x26.4x2.8x
Sat, 10 Sep 2022JP¥37.7tJP¥13.3tJP¥1.4t18x26.3x2.8x
Mon, 08 Aug 2022JP¥36.0tJP¥13.3tJP¥1.4t18.1x25x2.7x
Wed, 06 Jul 2022JP¥36.1tJP¥13.1tJP¥1.5t18.4x24.7x2.8x
Fri, 03 Jun 2022JP¥34.6tJP¥13.1tJP¥1.5t18x23.7x2.6x
Sun, 01 May 2022JP¥35.6tJP¥13.0tJP¥1.6t18.9x22.1x2.7x
Tue, 29 Mar 2022JP¥35.1tJP¥12.8tJP¥1.5t20.5x22.6x2.7x
Thu, 24 Feb 2022JP¥34.1tJP¥12.8tJP¥1.5t17.8x22x2.7x
Sat, 22 Jan 2022JP¥33.0tJP¥12.5tJP¥1.6t16.8x20.8x2.6x
Mon, 20 Dec 2021JP¥33.8tJP¥12.5tJP¥1.6t18.1x21.3x2.7x
Wed, 17 Nov 2021JP¥36.5tJP¥12.5tJP¥1.6t19.6x22.8x2.9x
Fri, 15 Oct 2021JP¥36.3tJP¥12.2tJP¥1.5t18.4x24.2x3x
Sun, 12 Sep 2021JP¥38.0tJP¥12.3tJP¥1.5t18.4x25.3x3.1x
Tue, 10 Aug 2021JP¥34.9tJP¥12.3tJP¥1.5t17.1x23.3x2.8x
Mon, 03 May 2021JP¥35.1tJP¥11.9tJP¥1.4t18.2x24.7x2.9x
Price to Earnings Ratio

24.7x


Total Market Cap: JP¥35.1tTotal Earnings: JP¥1.4tTotal Revenue: JP¥11.9tTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Pharma Industry Price to Earnings3Y Average 26.2x202220232024
Current Industry PE
  • Investors are optimistic on the Japanese Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 32.8x which is higher than its 3-year average PE of 26.1x.
  • The industry is trading close to its 3-year average PS ratio of 2.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 5.3% per year over the last three years.
  • Meanwhile revenues for these companies have grown 7.4% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Japanese Pharma compare with similar industries?

JP Market-0.51%
Healthcare0.69%
Pharma0.53%
Pharma0.53%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4568 Daiichi Sankyo CompanyJP¥4.77k5.1%
+JP¥441.0b
1.2%PE49.1x
4523 EisaiJP¥6.26k7.5%
+JP¥124.8b
-19.3%PE39.5x
4578 Otsuka HoldingsJP¥6.27k1.3%
+JP¥42.3b
38.1%PE28x
4536 Santen PharmaceuticalJP¥1.49k3.4%
+JP¥17.7b
36.3%PE19.6x
4516 Nippon ShinyakuJP¥4.31k1.5%
+JP¥4.2b
-29.7%PE12x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4503

JP¥1,455.00

Astellas Pharma

7D

-0.7%

1Y

-26.6%

4568

JP¥4,766.00

Daiichi Sankyo Company

7D

5.1%

1Y

1.2%

4523

JP¥6,259.00

Eisai

7D

7.5%

1Y

-19.3%

4519

JP¥4,860.00

Chugai Pharmaceutical

7D

-4.5%

1Y

41.7%

4506

JP¥400.00

Sumitomo Pharma

7D

1.5%

1Y

-52.7%

4565

JP¥1,495.00

Nxera Pharma

7D

-1.1%

1Y

-42.6%

4530

JP¥3,710.00

Hisamitsu Pharmaceutical

7D

-0.7%

1Y

0.7%

4528

JP¥2,269.50

Ono Pharmaceutical

7D

-1.4%

1Y

-16.9%

4536

JP¥1,491.50

Santen Pharmaceutical

7D

3.4%

1Y

36.3%

4521

JP¥3,389.00

Kaken Pharmaceutical

7D

-1.0%

1Y

-8.4%